Back to Search Start Over

The Definition, Rationale, and Effects of Thresholding in OCT Angiography.

Authors :
Cole ED
Moult EM
Dang S
Choi W
Ploner SB
Lee B
Louzada R
Novais E
Schottenhamml J
Husvogt L
Maier A
Fujimoto JG
Waheed NK
Duker JS
Source :
Ophthalmology. Retina [Ophthalmol Retina] 2017 Sep-Oct; Vol. 1 (5), pp. 435-447. Date of Electronic Publication: 2017 Apr 05.
Publication Year :
2017

Abstract

Purpose: To examine the definition, rationale, and effects of thresholding in OCT angiography (OCTA).<br />Design: A theoretical description of OCTA thresholding in combination with qualitative and quantitative analysis of the effects of OCTA thresholding in eyes from a retrospective case series.<br />Participants: Four eyes were qualitatively examined: 1 from a 27-year-old control, 1 from a 78-year-old exudative age-related macular degeneration (AMD) patient, 1 from a 58-year-old myopic patient, and 1 from a 77-year-old nonexudative AMD patient with geographic atrophy (GA). One eye from a 75-year-old nonexudative AMD patient with GA was quantitatively analyzed.<br />Main Outcome Measures: A theoretical thresholding model and a qualitative and quantitative description of the dependency of OCTA on thresholding level.<br />Results: Due to the presence of system noise, OCTA thresholding is a necessary step in forming OCTA images; however, thresholding can complicate the relationship between blood flow and OCTA signal.<br />Conclusions: Thresholding in OCTA can cause significant artifacts, which should be considered when interpreting and quantifying OCTA images.<br />Competing Interests: Conflicts of Interest: J.S.D.: Consultant and research support — Carl Zeiss Meditec, OptoVue, and Topcon Medical Systems Inc; stock — Hemera Biosciences Inc, EyeNetra, and Ophthotech Corp. N.K.W.: Consultant — Iconic Therapeutics; speaker’s bureau —ThromboGenics; research support — Carl Zeiss Meditec, Inc. J.G.F.: Royalties — intellectual property owned by the Massachusetts Institute of Technology and licensed to Carl Zeiss Meditec Inc, Optovue Inc; stock options — Optovue Inc. There are no conflicting relationships for any other author.

Details

Language :
English
ISSN :
2468-7219
Volume :
1
Issue :
5
Database :
MEDLINE
Journal :
Ophthalmology. Retina
Publication Type :
Academic Journal
Accession number :
29034359
Full Text :
https://doi.org/10.1016/j.oret.2017.01.019